Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Clinicopathological features and prognosis factors for survival in elderly patients with pancreatic neuroendocrine tumor: A STROBE-compliant article.

Li G, Tian ML, Bing YT, Tao LY, Wang HY, Jiang B, Yuan CH, Xiu DR.

Medicine (Baltimore). 2019 Mar;98(11):e14576. doi: 10.1097/MD.0000000000014576.

2.

Racial disparities in pancreatic neuroendocrine tumors survival: a SEER study.

Zhou H, Zhang Y, Wei X, Yang K, Tan W, Qiu Z, Li S, Chen Q, Song Y, Gao S.

Cancer Med. 2017 Nov;6(11):2745-2756. doi: 10.1002/cam4.1220. Epub 2017 Oct 4.

3.

Prognostic Value of Lymph Node Status and Extent of Lymphadenectomy in Pancreatic Neuroendocrine Tumors Confined To and Extending Beyond the Pancreas.

Conrad C, Kutlu OC, Dasari A, Chan JA, Vauthey JN, Adams DB, Kim M, Fleming JB, Katz MH, Lee JE.

J Gastrointest Surg. 2016 Dec;20(12):1966-1974. Epub 2016 Oct 6.

PMID:
27714644
4.

Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States.

Gratian L, Pura J, Dinan M, Roman S, Reed S, Sosa JA.

Ann Surg Oncol. 2014 Oct;21(11):3515-21. doi: 10.1245/s10434-014-3769-4. Epub 2014 May 20.

5.

Importance of lymph node involvement in pancreatic neuroendocrine tumors: impact on survival and implications for surgical resection.

Curran T, Pockaj BA, Gray RJ, Halfdanarson TR, Wasif N.

J Gastrointest Surg. 2015 Jan;19(1):152-60; discussion 160. doi: 10.1007/s11605-014-2624-z. Epub 2014 Aug 14.

PMID:
25118642
6.

Marital status is an independent prognostic factor for pancreatic neuroendocrine tumors patients: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database.

Zhou H, Zhang Y, Song Y, Tan W, Qiu Z, Li S, Chen Q, Gao S.

Clin Res Hepatol Gastroenterol. 2017 Sep;41(4):476-486. doi: 10.1016/j.clinre.2017.02.008. Epub 2017 Apr 14.

PMID:
28416359
7.

Surgical resection of the primary tumor leads to prolonged survival in metastatic pancreatic neuroendocrine carcinoma.

Feng T, Lv W, Yuan M, Shi Z, Zhong H, Ling S.

World J Surg Oncol. 2019 Mar 21;17(1):54. doi: 10.1186/s12957-019-1597-5.

8.

Neuroendocrine Liver Metastasis: Prognostic Implications of Primary Tumor Site on Patients Undergoing Curative Intent Liver Surgery.

Spolverato G, Bagante F, Aldrighetti L, Poultsides G, Bauer TW, Field RC, Marques HP, Weiss M, Maithel SK, Pawlik TM.

J Gastrointest Surg. 2017 Dec;21(12):2039-2047. doi: 10.1007/s11605-017-3491-1. Epub 2017 Jul 25.

PMID:
28744737
9.

Pancreatic neuroendocrine tumors: the impact of surgical resection on survival.

Hill JS, McPhee JT, McDade TP, Zhou Z, Sullivan ME, Whalen GF, Tseng JF.

Cancer. 2009 Feb 15;115(4):741-51. doi: 10.1002/cncr.24065.

10.

Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.

Oweira H, Petrausch U, Helbling D, Schmidt J, Mannhart M, Mehrabi A, Schöb O, Giryes A, Decker M, Abdel-Rahman O.

World J Gastroenterol. 2017 Mar 14;23(10):1872-1880. doi: 10.3748/wjg.v23.i10.1872.

11.

Prognostic factors and survival after surgical resection of pancreatic neuroendocrine tumor with validation of established and modified staging systems.

Benetatos N, Hodson J, Marudanayagam R, Sutcliffe RP, Isaac JR, Ayuk J, Shah T, Roberts KJ.

Hepatobiliary Pancreat Dis Int. 2018 Apr;17(2):169-175. doi: 10.1016/j.hbpd.2018.03.002. Epub 2018 Mar 6.

PMID:
29576279
12.

Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs).

Hashim YM, Trinkaus KM, Linehan DC, Strasberg SS, Fields RC, Cao D, Hawkins WG.

Ann Surg. 2014 Feb;259(2):197-203. doi: 10.1097/SLA.0000000000000348.

13.

Pancreastatin predicts survival in neuroendocrine tumors.

Sherman SK, Maxwell JE, O'Dorisio MS, O'Dorisio TM, Howe JR.

Ann Surg Oncol. 2014 Sep;21(9):2971-80. doi: 10.1245/s10434-014-3728-0. Epub 2014 Apr 22.

14.

Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size.

Kuo EJ, Salem RR.

Ann Surg Oncol. 2013 Sep;20(9):2815-21. doi: 10.1245/s10434-013-3005-7. Epub 2013 Jun 15.

PMID:
23771245
15.

Significance of lymph node metastasis in pancreatic neuroendocrine tumor.

Taki K, Hashimoto D, Nakagawa S, Ozaki N, Tomiyasu S, Ohmuraya M, Arima K, Kaida T, Higashi T, Sakamoto K, Sakata K, Okabe H, Nitta H, Hayashi H, Chikamoto A, Beppu T, Takamori H, Hirota M, Baba H.

Surg Today. 2017 Sep;47(9):1104-1110. doi: 10.1007/s00595-017-1485-y. Epub 2017 Feb 22.

PMID:
28229300
16.

Impact of marital status at diagnosis on survival and its change over time between 1973 and 2012 in patients with nasopharyngeal carcinoma: a propensity score-matched analysis.

Xu C, Liu X, Chen YP, Mao YP, Guo R, Zhou GQ, Tang LL, Lin AH, Sun Y, Ma J.

Cancer Med. 2017 Dec;6(12):3040-3051. doi: 10.1002/cam4.1232. Epub 2017 Oct 16.

17.

Indications for Surgical Resection in Low-Grade Pancreatic Neuroendocrine Tumors.

Fitzgerald TL, Mosquera C, Vora HS, Vohra NA, Zervos EE.

Am Surg. 2016 Aug;82(8):737-42.

PMID:
27657591
18.

Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.

Madden NA, Macdonald OK, Call JA, Schomas DA, Lee CM, Patel S.

Am J Clin Oncol. 2016 Oct;39(5):458-62. doi: 10.1097/COC.0000000000000078.

PMID:
24781343
19.

Neoadjuvant radiation followed by resection versus upfront resection for locally advanced pancreatic cancer patients: a propensity score matched analysis.

Chen X, Liu G, Wang K, Chen G, Sun J.

Oncotarget. 2017 Jul 18;8(29):47831-47840. doi: 10.18632/oncotarget.18091.

20.

Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification.

Tsutsumi K, Ohtsuka T, Fujino M, Nakashima H, Aishima S, Ueda J, Takahata S, Nakamura M, Oda Y, Tanaka M.

J Hepatobiliary Pancreat Sci. 2014 Jun;21(6):418-25. doi: 10.1002/jhbp.47. Epub 2013 Oct 20.

PMID:
24142395

Supplemental Content

Support Center